[HTML][HTML] Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences

ND Vaziri - Kidney international, 2016 - Elsevier
Nephrotic syndrome results in hyperlipidemia and profound alterations in lipid and
lipoprotein metabolism. Serum cholesterol, triglycerides, apolipoprotein B (apoB) …

Mechanisms and treatment of dyslipidemia in diabetes

E Bahiru, R Hsiao, D Phillipson, KE Watson - Current cardiology reports, 2021 - Springer
Abstract Purpose of Review Type 2 diabetes mellitus is widespread throughout the world
and is a powerful risk factor for the development of atherosclerotic cardiovascular disease …

RNA editing underlies genetic risk of common inflammatory diseases

Q Li, MJ Gloudemans, JM Geisinger, B Fan, F Aguet… - Nature, 2022 - nature.com
A major challenge in human genetics is to identify the molecular mechanisms of trait-
associated and disease-associated variants. To achieve this, quantitative trait locus (QTL) …

HDL abnormalities in nephrotic syndrome and chronic kidney disease

ND Vaziri - Nature Reviews Nephrology, 2016 - nature.com
Normal HDL activity confers cardiovascular and overall protection by mediating reverse
cholesterol transport and through its potent anti-inflammatory, antioxidant, and …

Emerging role of high density lipoproteins as a player in the immune system

GD Norata, A Pirillo, E Ammirati, AL Catapano - Atherosclerosis, 2012 - Elsevier
High density lipoproteins (HDL) possess a number of physiological activities. The most
studied and, perhaps, better understood is the ability of HDL to promote excess cholesterol …

[HTML][HTML] Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!

S Nazir, V Jankowski, G Bender, S Zewinger… - Advanced Drug Delivery …, 2020 - Elsevier
High-density lipoprotein (HDL) plays an important role in lipid metabolism and especially
contributes to the reverse cholesterol transport pathway. Over recent years it has become …

[HTML][HTML] Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases

Y Wang, H Yu, J He - Discovery Medicine, 2020 - discoverymedicine.com
Dyslipidemia refers to the abnormality of lipid metabolism. The aberrant lipid profiles are
usually characterized by elevated plasma levels of low-density lipoprotein cholesterol (LDL …

The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases

S Park, KW Mathis, IK Lee - Reviews in Endocrine and Metabolic Disorders, 2014 - Springer
Several isoforms of apolipoprotein J/clusterin (CLU) are encoded from a single gene located
on chromosome 8 in humans. These isoforms are ubiquitously expressed in the tissues, and …

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function [S]

CE Watson, N Weissbach, L Kjems… - Journal of lipid …, 2011 - ASBMB
L-4F, an apolipoprotein AI (apoA-I) mimetic peptide (also known as APL180), was
administered daily by either intravenous (IV) infusion for 7 days or by subcutaneous (SC) …

High-density lipoprotein (HDL) dysfunction and the future of HDL

S Ertek - Current vascular pharmacology, 2018 - ingentaconnect.com
Although High Density Lipoprotein Cholesterol (HDL-C) levels are inversely proportional to
cardiovascular risk in many studies, recent pharmacological interventional studies with HDL …